Molecular diagnostic company Genetic Signatures has submitted an application seeking US Food and Drug Administration approval for its EasyScreen Gastrointestinal Parasite Detection Kit. The easy to use kit aims to replace current screening methods which involve sample culturing and microscopic inspection, antigen detection and pathogen-specific molecular tests, Genetic Signatures said the US market for the…
Molecular diagnostic company Genetic Signatures has reported year to date sales of $23 million for the nine months to March 31, more than double its full year revenue in the previous financial year. Third quarter sales were $4.3 million including instrument sales of $300,000, up 136 per cent on the previous corresponding period. The company…
IDT Australia to raise $7 million for mRNA vaccine production Pharmaceutical manufacturer IDT Australia is to raise $7 million a fully underwritten entitlement offer of fully paid ordinary shares to eligible shareholders. The funds raised will be used to fund capital expenditure relating to current and potential future works in the mRNA therapeutics field including…
Medical technology developer and contract manufacturer Neo-Bionica, which announced an investment of $5 million from Breakthrough Victoria earlier this month, has announced two new board appointments. In a statement on Monday, the company said it had added Stéphane Chatonsky and Dr Colin White as non-executive directors. “Their extensive expertise in innovation in MedTech, strategy and…
